.Basilea Pharmaceutica's job developing brand-new antifungals has actually gotten a significant boos...
.Possessing presently gathered up the USA legal rights to Capricor Rehabs' late-stage Duchenne muscu...
.After pushing the decision meeting for Applied Therapeutics' metabolic disorder drug govorestat, th...
.Novo Nordisk is actually proceeding its own push in to genetic medicines, agreeing to pay NanoVatio...
.Innovent Biologics has created the instance that its gate inhibitor-cytokine fusion protein has a f...
.A stage 3 test of Daiichi Sankyo as well as Merck & Co.'s HER3-directed antibody-drug conjugate ...
.5 months after Rakovina Therapeutics pivoted toward artificial intelligence, the cancer-focused bio...
.Ascendis Pharma has actually become a possible hazard to BioMarin's Voxzogo, disclosing stage 3 gro...
.Though Alkeus Pharmaceuticals' oral eye disease asset failed to significantly lessen geographical a...
.Along with a trio of biotechs reaching the Nasdaq on Friday, it was actually simple to overlook a s...
.Invulnerable checkpoint inhibitors are actually the superheroes of cancer cells therapy. Medication...
.Welcome to today's Chutes & Ladders, our summary of substantial management hirings, firings and ...
.Regeneron is back with lasting consequence for its LAG-3 inhibitor and also PD-1 prevention combo i...
.AstraZeneca has discussed a very early look at the functionality of its own internal antibody-drug ...
.After declaring a phase 3 launch based upon good midstage outcomes, iTeos and GSK are actually even...
.The FDA needs to be much more open and also collaborative to release a rise in commendations of unc...
.It's an unusually hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bicara Therap...
.Atea Pharmaceuticals' antiviral has actually neglected an additional COVID-19 trial, however the bi...
.Neurocrine Biosciences' schizophrenia system pivot has actually fallen short. The biotech was incap...
.Sanofi has made a late access to the radioligand party, paying one hundred thousand euros ($ 110 mi...